All Things Cardio-Oncology

Dr. Alexia Oliver opened our 2025 Global Summit sharing her harrowing account of being on the brink of completing her medical training only to discover she had an aggressive lymphoma. Her treatment was followed by chemotherapy-induced heart failure so severe she was placed on the transplant list, yet she slowly recovered against all expectations. After additional setbacks—including bilateral hip replacements—she returned to medical school with a renewed sense of purpose, grounded in the conviction that having a “why” makes survival possible. She embodies the reason our community exists, you won't want to miss this episode.

Dr. James Wilson is a consultant clinical oncologist in the UK who specializes in lung and skin cancers. He works at several London hospitals, including the London Clinic, The Cromwell Hospital, and Leaders in Oncology Care (LOC), and also has an NHS base at University College London Hospital (UCLH). His expertise includes treatments like advanced radiotherapy (such as SABR and CyberKnife), chemotherapy, and immunotherapy, and he is involved in research and clinical trials.

Francesca Ossani survived breast cancer and cardiovascular complications of her cancer therapy but discovered beauty and hope along the way. She discovered the value of collaborative medical care and the hope of sharing the journey with others. She now continues to spread hope and joy in her volunteer work at a pediatric cancer center. Join us as we hear of her remarkable story of hope and joy in the face of incredible challenges.

As part of our 2025 Board Review Course Dr. Mahmood provides insights into the contemporary state of our understanding of CAR T therapies, their CV risk, and management. You can purchase the complete set of review course videos at the link below. This includes modules covering the Management & Detection of Cardiac Dysfunction, Toxicities of Traditional Therapies, Hematology, and Immunotherapy.https://members.ic-os.org/store/viewproduct.aspx?id=26378193

As part of our 2025 Board review course Dr. Fradley reviews some key articles that promise to shape the future of clinical practice.You can purchase the complete set of review course videos at the link below. This includes modules covering the Management & Detection of Cardiac Dysfunction, Toxicities of Traditional Therapies, Hematology, and Immunotherapy.https://members.ic-os.org/store/viewproduct.aspx?id=26378193

Dr. Novi Tham, President of IC-OS Indonesia inspires us with her account of establishing the first cardio-oncology clinic in her country. She currently serves as cardio-oncology director at Siloam Hospitals Lippo Village.

Markus S. Anker, MD, Department of Cardiology, Charité, Hindenburgdamm 30, 12203 Berlin, Germany. Here the team discusses a recent clinical trial related to cancer patients in the palliative care setting being treated for heart failure. You can read the full article here: https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehaf705/8242490

Taryn Cox was diagnosed with breast cancer while living in remote parts of southern Africa. Her story of tenacity and courage to get proper care is an inspiration for all of us.

In this episode we hear an update about the ongoing challenges of working in Ukraine along with the resiliance and productivity of the team there in spite of the circumstances. Dr. Kozhukov serves at Kyiv Medical University and the National Stiencific Center The M.D.Strazhesko Institute of Cardiology. Dr. Nataliia Dovganych serves at The M.D.Strazhesko Institute of Cardiology and Uzhgorod State University. Dr. Eugene Storozynsky, is Professor of Medicine and Oncology, Jefferson Health Enterprise Chief of Cardio-Oncology, Toll Heart and Vascular Institute, Sidney Kimmel Medical College-Thomas Jefferson University.

We caoght up with IC-OS Poland President Sebastian Szmit at the Multinational Association of Supportive Care in Cancer (MASCC) meeting for a quick update on cardio-oncology developments in Poland.

Dr Olga Toro-Salazar is a Paediatric Cardiologist and founded and directs the cardiovascular MRI and cardio-oncology programmes at Connecticut Children's Medical Center, Connecticut, US. Dr Toro-Salazar's expertise is in advanced echocardiographic techniques and cardiac magnetic resonance imaging (CMRI). They have a special interest in myocardial mechanics and tissue characterisation.In this episode she discusses Cardiac Magnetic Resonance Imaging in the Assessment of Cardiac Injury and Toxicity from Cancer‑Related Chemotherapy.You can view the original webinar in its entirely at the link below:https://www.radcliffecardiology.com/webinars/cardiac-magnetic-resonance-imaging-assessment-cardiac-injury-and-toxicity-cancer-related

Amy's treatment was nearly suspended due to cardiovascular complications. Cardio-Oncology intervened allowing her to continue life saving therapy. You don't want to miss her story. Amy explains of herself, "Originally from Lincoln, Nebraska, I’m a proud graduate of the University of Nebraska–Lincoln with a degree in Elementary Education and hold a Master’s from Northwest Missouri State. I’ve been married to my high school sweetheart for 33 years, and we have four amazing kids—two grown and married, plus a 14-year-old and a 12-year-old who keep us on our toes. I’m starting my 27th year of teaching and currently teach 3rd grade in Liberty, Missouri."

Dr. Susan Dent is a Medical Oncologist at the Wilmot Cancer Institute, Professor of Medicine and Director of Cardio Oncology at the University of Rochester. She is also President of the International Cardio-Oncology Society. In this podcast she provides a summary of a talk originally presented at the ASCO meeting in 2025.

Samantha Siegel, MD is an internal medicine physician with Kaiser Permanente. She explains, "I began my primary care practice with a thorough understanding of advanced disease processes that often result in hospitalization and the type of care people need when they transition back home. Then, I was diagnosed with Hodgkin Lymphoma and underwent over two years of intensive cancer treatment, including an autologous bone marrow transplant. This led me to study integrative medicine and to focus my practice on the evolving field of cancer survivorship." You will be encouraged to hear how she has negotiated her own survivorship as a medical professional.

In this episode we learn about some of the exciting developments in the cardio-oncology movement in Thailand from its key leaders. Dr. June Tanking is Associate Professor of medicine at Chulabhorn hospital and the royal academy in Bangkok, Thailand. She is joined by her colleauge Dr. Deborah Sundlof who is the Cardio-Oncology Director at Leighigh Valley Health, an IC-OS Center of Excellence. To learn more about the IC-OS Global Training Course email Steve Casselli at StephenCasselli@ic-os.org.

A cardiologist by training, Isabelle Mahé is Professor of Internal Medicine at Université Paris Cité. She is Head of the Internal Medicine Department at a teaching hospital (Louis Mourier, Assistance Publique Hôpitaux de Paris, Paris, France), which includes an oncology unit and a vascular disease unit. She established a tele-expertise service to help physicians manage patients with anticoagulant concerns. She is also chair of the scientific council for the INNOVTE-FCRIN Network (Investigation Network On Venous Thrombo-Embolism) and for a patients' association for anticoagulant therapy (Anticoag PASS S2D). She has broad experience in methodology and in clinical trials evaluating anticoagulants in different cardiologic or vascular indications. Her own research projects have resulted in a better management of anticoagulants in complex patients (renally impaired, elderly and cancer patients. She is leading the international prospective randomised API-CAT Study (focusing on the extended anticoagulant treatment in patients with cancer-associated thrombosis).Sebastian Szmit graduated from the Military Medical Academy in Poland (2002). From 2002 to 2012 he worked at the Military Institute of Medicine in the (1) Emergency Department, (2) Department of Internal Medicine and Cardiology, (3) Department of Oncology. From 2012 to 2022 he was employed by the Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology as cardiologist consultant of the Department of Oncology at the European Health Centre Otwock. In December 2022 he was appointed the Head of the Department of Cardio-Oncology, Centre of Postgraduate Medical Education at the Institute of Hematology and Transfusion Medicine & Consultant of the Cancer Diagnostics and Cardio-Oncology at the Maria Skłodowska-Curie National Research Institute of Oncology (Warsaw, Poland). He is cardiologist & clinical oncologist.Read the full trial results here: https://www.nejm.org/doi/full/10.1056/NEJMoa2416112

An engaging three-part podcast series designed to empower oncology nurses and advanced practice providers with the knowledge and practical tools needed to support patients with chronic lymphocytic leukemia (CLL) undergoing treatment with BTK inhibitors. Each episode brings clinical insights and evidence-based strategies to the forefront, helping nurses navigate the complexities of the BTK inhibitor therapy from both a pharmacological and patient care perspective.INSTRUCTIONS FOR PARTICIPATION AND REQUESTING CREDITThere are no fees for participating and receiving credit for this activity. Successful completion is achieved by reviewing the CE information, completing the pre-test, completing the activity, and completing the post-test and evaluation form. A score of at least 50% on the posttest is required to successfully complete this activity. The participant may take the test until successfully passed.Credit Fulfillment• If you are requesting AMA credits, ANCC credits, AAPA credits, or a certificate of participation, your certificate will be available for download For credited course go to: https://www.francefoundation.com/content/9457-btki/ic-os-launch.phpThis activity is jointly provided by The France Foundation and the Internation Cardio-Oncology Society and supported by independent medical educational grants from AstraZeneca and Lilly.

An engaging three-part podcast series designed to empower oncology nurses and advanced practice providers with the knowledge and practical tools needed to support patients with chronic lymphocytic leukemia (CLL) undergoing treatment with BTK inhibitors. Each episode brings clinical insights and evidence-based strategies to the forefront, helping nurses navigate the complexities of the BTK inhibitor therapy from both a pharmacological and patient care perspective.INSTRUCTIONS FOR PARTICIPATION AND REQUESTING CREDITThere are no fees for participating and receiving credit for this activity. Successful completion is achieved by reviewing the CE information, completing the pre-test, completing the activity, and completing the post-test and evaluation form. A score of at least 50% on the posttest is required to successfully complete this activity. The participant may take the test until successfully passed.Credit Fulfillment• If you are requesting AMA credits, ANCC credits, AAPA credits, or a certificate of participation, your certificate will be available for download For credited course go to: https://www.francefoundation.com/content/9457-btki/ic-os-launch.phpThis activity is jointly provided by The France Foundation and the Internation Cardio-Oncology Society and supported by independent medical educational grants from AstraZeneca and Lilly.

An engaging three-part podcast series designed to empower oncology nurses and advanced practice providers with the knowledge and practical tools needed to support patients with chronic lymphocytic leukemia (CLL) undergoing treatment with BTK inhibitors. Each episode brings clinical insights and evidence-based strategies to the forefront, helping nurses navigate the complexities of the BTK inhibitor therapy from both a pharmacological and patient care perspective.INSTRUCTIONS FOR PARTICIPATION AND REQUESTING CREDITThere are no fees for participating and receiving credit for this activity. Successful completion is achieved by reviewing the CE information, completing the pre-test, completing the activity, and completing the post-test and evaluation form. A score of at least 50% on the posttest is required to successfully complete this activity. The participant may take the test until successfully passed.Credit Fulfillment• If you are requesting AMA credits, ANCC credits, AAPA credits, or a certificate of participation, your certificate will be available for download For credited course go to: https://www.francefoundation.com/content/9457-btki/ic-os-launch.phpThis activity is jointly provided by The France Foundation and the Internation Cardio-Oncology Society and supported by independent medical educational grants from AstraZeneca and Lilly.

Adina Isenberg is a cancer survivor and patient advocate who has made a lasting difference in countless lives by lobbying for legislative changes, mentoring survivors and teaching in both business and medical settings. You will be encouraged and challened by her hopeful optimism.